Sundaram Multi Pap Ltd Falls 1.49%: Valuation Upgrade Amidst Continued Underperformance

29 June 2026: Week Commences with Rs.1.34 Close

The stock opened the week at Rs.1.34 on 29 June 2026, with a volume of 70,003 shares traded. The Sensex closed at 35,960.98, setting a neutral baseline for the week. Sundaram Multi Pap Ltd’s price level was near the upper end of its recent trading range, but market activity was subdued, reflecting cautious investor sentiment ahead of anticipated news.

30 June 2026: Early Week Decline Amid Flat Market

On 30 June, the stock declined by 1.49% to Rs.1.32, with volume rising to 118,952 shares. This drop contrasted with the Sensex’s marginal 0.01% decline, signalling relative weakness in the stock. The lack of positive catalysts and ongoing concerns about the company’s fundamentals likely contributed to this underperformance.

1 July 2026: MarketsMOJO Upgrades Rating to Sell

On 1 July, Sundaram Multi Pap Ltd’s investment rating was upgraded from 'Strong Sell' to 'Sell' by MarketsMOJO, reflecting improved valuation and financial trends. The stock closed unchanged at Rs.1.32, with volume moderating to 43,614 shares. The Sensex gained 0.45%, closing at 36,119.01, indicating broader market strength that the stock did not fully participate in.

The upgrade was driven by a shift in valuation grade from 'attractive' to 'very attractive', supported by a price-to-earnings (PE) ratio of 22.66 and a price-to-book value (P/BV) of 0.69. These metrics suggest the stock is trading below its net asset value and at a discount relative to peers such as Kokuyo Camlin (PE 35.62) and Linc (PE 20.07). Additionally, enterprise value multiples like EV/EBITDA at 14.27 and a PEG ratio of 0.12 underscored the stock’s undervaluation relative to earnings growth potential.

2 July 2026: Valuation Shift Highlights Value Despite Challenges

The following day, 2 July, the stock slipped further to Rs.1.31 (-0.76%) on volume of 48,709 shares, while the Sensex surged 0.71% to 36,376.02. This divergence emphasised the stock’s continued underperformance despite the positive rating change.

MarketsMOJO’s detailed analysis highlighted that Sundaram Multi Pap Ltd’s valuation had shifted to 'very attractive' amidst prolonged underperformance. The company’s PE ratio of 22.66 and P/BV of 0.69 remain compelling relative to peers, though the EV/EBITDA multiple of 14.27 is somewhat elevated compared to Linc’s 11.15. The PEG ratio of 0.12 suggests undervaluation relative to earnings growth, but weak returns on capital employed (1.98%) and equity (3.04%) continue to weigh on sentiment.

Financially, the company reported its highest net sales in Q4 FY25-26 at ₹44.35 crores, with profit after tax surging 211.6% to ₹1.06 crore, marking a third consecutive quarter of positive results. However, long-term financial strength remains limited, with an average EBIT to interest coverage ratio of just 0.61, indicating vulnerability to debt servicing pressures.

3 July 2026: Week Closes with Slight Recovery

On the final trading day of the week, 3 July, Sundaram Multi Pap Ltd rebounded slightly to close at Rs.1.32 (+0.76%) on volume of 73,920 shares. The Sensex also advanced 0.15% to 36,431.45. Despite this minor recovery, the stock ended the week down 1.49%, underperforming the Sensex’s 1.31% gain.

The stock’s 52-week range remains wide, from a low of Rs.1.06 to a high of Rs.2.40, reflecting ongoing volatility and limited upward momentum. The MarketsMOJO Mojo Score stands at 32.0 with a 'Sell' grade, signalling cautious optimism amid persistent structural challenges.

Daily Price Performance: Sundaram Multi Pap Ltd vs Sensex

Key Takeaways from the Week

Valuation Upgrade Signals Value Opportunity: The upgrade to a 'Sell' rating from 'Strong Sell' was primarily driven by improved valuation metrics, including a PE ratio of 22.66 and a P/BV of 0.69, positioning Sundaram Multi Pap Ltd as a relatively undervalued stock within its peer group.

Financial Trends Show Positive Momentum: The company reported its highest quarterly net sales of ₹44.35 crores and a 211.6% surge in PAT to ₹1.06 crore in Q4 FY25-26, marking a potential operational turnaround after consecutive positive quarters.

Persistent Structural Challenges Remain: Despite recent improvements, long-term financial quality remains weak, with low returns on capital employed (1.98%) and equity (3.04%), and poor debt servicing ability (EBIT to interest coverage ratio of 0.61), which continue to weigh on investor confidence.

Underperformance Relative to Sensex: The stock declined 1.49% over the week while the Sensex gained 1.31%, highlighting ongoing market scepticism and limited technical momentum despite fundamental improvements.

Micro-Cap Status Limits Liquidity: The company’s micro-cap classification and predominantly non-institutional shareholder base contribute to volatility and constrained liquidity, factors that may deter broader institutional participation.

Conclusion

Sundaram Multi Pap Ltd’s week was characterised by a cautious yet notable upgrade in its investment rating, reflecting improved valuation and recent financial performance. However, the stock’s price action lagged the broader market, underscoring persistent concerns about long-term profitability, operational efficiency, and market positioning. The 'Sell' rating signals a tempered optimism, suggesting that while the stock may offer value relative to peers, significant risks remain. Investors should carefully weigh the company’s improving fundamentals against its structural challenges and micro-cap risks before considering exposure.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →